Cell Therapy Market
Cell Therapy Market - Global Industry Assessment & Forecast
Segments Covered
- By Use-Type Clinical Use, Research Use
- By Type Autologous Therapies, Allogenic Therapies
- By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 11.21 Billion |
Revenue 2030: | USD 27.95 Billion |
Revenue CAGR (2023 - 2030): | 12.10% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Research Methodology: Cell Therapy Market by Use-Type by Type by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
FAQ
Frequently Asked Question
What is the global demand for Cell Therapy in terms of revenue?
-
The global Cell Therapy valued at USD 11.21 Billion in 2022 and is expected to reach USD 27.95 Billion in 2030 growing at a CAGR of 12.10%.
Which are the prominent players in the market?
-
The prominent players in the market are The major companies of the studied market are Pharmicell Co. Ltd, Corestem Inc., Chiesi Farmaceutici SpA, Tegoscience, Anterogen Co. Ltd, TiGenix (Takeda Pharmaceuticals), Stempeutics Research Pvt Ltd, Nipro Corporation, and Medipost Co. Ltd..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 12.10% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cell Therapy include
- Rising Government Investments in Cell-Based Research
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cell Therapy in 2022.